A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease
Clinical trial NCT05193201 · UNKNOWN
Trial details
- NCT number
- NCT05193201
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-16
- Primary completion
- 2022-10-16
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.